Literature DB >> 20471440

Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children.

Guo-Lin Bian1, Rui Ma, Hong-Jun Dong, Hong-Xia Ni, Feng-Jiao Hu, Yao-Rong Chen, Jia-Qun Chen, Shao-Ying Zhou, Yong-Xin Lin, Guo-Zhang Xu.   

Abstract

110 children who were given the complete course of the inactivated hepatitis A vaccine (Havrix) were followed up 10 years later. Age-matched healthy children who were not inoculated served as controls. One month after two primary injections, all children were positive for serum antibody. After 10 years, 99.09% of inoculated children remained positive for serum anti-HAV antibody, with a geometric mean concentration (GMC) of 61.59mIU/mL. GMC values following a secondary immunization in children with antibody levels <20mIU/mL were significantly elevated (567.9mIU/mL), compared with the primary injection alone. Havrix appears to induce persistent immunity and potent immune memory. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471440     DOI: 10.1016/j.vaccine.2010.04.096

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.

Authors:  Vladimir Gilca; Chantal Sauvageau; Nicole Boulianne; Gaston De Serres; Michel Couillard; Mel Krajden; Manale Ouakki; Donald Murphy; Andrea Trevisan; Marc Dionne
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children.

Authors:  Gregory A Raczniak; Timothy K Thomas; Lisa R Bulkow; Susan E Negus; Carolyn L Zanis; Michael G Bruce; Philip R Spradling; Eyasu H Teshale; Brian J McMahon
Journal:  Vaccine       Date:  2013-03-05       Impact factor: 3.641

3.  Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series.

Authors:  Gregory A Raczniak; Lisa R Bulkow; Michael G Bruce; Carolyn L Zanis; Richard L Baum; Mary M Snowball; Kathy K Byrd; Umid M Sharapov; Thomas W Hennessy; Brian J McMahon
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

4.  Persistence of seropositivity among persons vaccinated for hepatitis A during infancy by maternal antibody status: 15-year follow-up.

Authors:  Philip R Spradling; Lisa R Bulkow; Susan E Negus; Chriss Homan; Michael G Bruce; Brian J McMahon
Journal:  Hepatology       Date:  2016-02-01       Impact factor: 17.425

Review 5.  Hepatitis B and A vaccination in HIV-infected adults: A review.

Authors:  G Mena; A L García-Basteiro; J M Bayas
Journal:  Hum Vaccin Immunother       Date:  2015-07-24       Impact factor: 3.452

Review 6.  Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.

Authors:  Anke L Stuurman; Cinzia Marano; Eveline M Bunge; Laurence De Moerlooze; Daniel Shouval
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

7.  Comparison of the immunogenicity and safety of 3 inactivated hepatitis A vaccines in Korean children aged 12 to 18 months: An open-label, randomized, prospective, multicenter study.

Authors:  Seung Soo Hong; Ui Yoon Choi; Sang Hyuk Ma; Soo Young Lee; Seung Beom Han; Kyung-Hyo Kim; Jin Han Kang; Jong-Hyun Kim
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

Review 8.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

9.  [Persistence of hepatitis A virus antibodies after primary immunization and response to revaccination in children and adolescents with perinatal HIV exposure].

Authors:  Aída de Fátima Thomé Barbosa Gouvêa; Maria Isabel de Moraes Pinto; Maristela Miyamoto; Daisy Maria Machado; Silvana Duarte Pessoa; Fabiana Bononi do Carmo; Suênia Cordeiro de Vasconcelos Beltrão; Regina Célia de Menezes Succi
Journal:  Rev Paul Pediatr       Date:  2015-03-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.